Abstract
Many infectious agents can cause central nervous system (CNS) diseases in humans. Since microbial agents infecting CNS are numerous and have different features, conventional laboratory tests may not be sensitive enough to identify and characterise viruses and bacteria in human biological specimens. Thus, the need to define methods for the diagnosis of infectious neurological diseases, such as progressive multifocal leukoencephalopathy (PML), is urgent, in order to improve the outcome of the diseases with rapid and accurate detection of the pathogens.
Similar content being viewed by others
References
Aberle SW, Puchhammer-Stockl E (2002) Diagnosis of herpesvirus infections of the central nervous system. J Clin Virol 25:S79–S85
Tebas P, Nease RF, Storch GA (1998) Use of the PCR in the diagnosis of herpes simplex encephalitis: a decision analysis model. Am J Med 105:287–295
Bestetti A, Pienotti C, Terreni M et al (2001) Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis. J Clin Microbiol 39:1148–1151
Walker DL, Padgett BL (1983) The epidemiology of human polyomaviruses. In: Sever JL, Madden D (eds) Polyomaviruses and human neurological disease. Alan R. Liss, New York, pp 99–106
Ferrante P, Caldarelli-Stefano R, Omodeo-Zorini E et al (1997) Comprehensive investigation of the presence of JC virus in AIDS patients with and without progressive multifocal leukoencephalopathy. J Med Virol 52:235–242
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delbue, S., Tremolada, S. & Ferrante, P. Application of molecular tools for the diagnosis of central nervous system infections. Neurol Sci 29 (Suppl 2), 283–285 (2008). https://doi.org/10.1007/s10072-008-0965-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-008-0965-7